[Full text] Resiquimod for Prostate Cancer Treatment
Purpose: With the advance of screening techniques, there is a growing number of low-risk or intermediate-risk prostate cancer (PCa) cases, remaining a serious threat to menโs health. To obtain better efficacy, a growing interest has been attracted to develop such emerging treatments as immunotherapy and focal therapy. However, few studies offer guidance on whether and how to combine these modalities against PCa. This study was designed to develop dual-functional nanoparticles (NPs) which comb...
United States United Kingdom Miltenyi Biotec Malvern Panalytical Zetasizer Nano Guideline Of Animal Experiment In Okayama University
Source: dovepress.com